Cargando…
Dermatologic events from EGFR inhibitors: the issue of the missing patient voice
PURPOSE: As epidermal growth factor receptor (EGFR) inhibitors are associated with a variety of dermatologic adverse events (dAEs), the purpose of this study was to develop an overview of current knowledge of dAEs associated with EGFR inhibitors and to identify knowledge gaps regarding incidence, tr...
Autores principales: | Tischer, Bernd, Huber, Renate, Kraemer, Matthias, Lacouture, Mario E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5196015/ https://www.ncbi.nlm.nih.gov/pubmed/27718067 http://dx.doi.org/10.1007/s00520-016-3419-4 |
Ejemplares similares
-
A survey of patient and physician acceptance of skin toxicities from anti-epidermal growth factor receptor therapies
por: Tischer, Bernd, et al.
Publicado: (2017) -
Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
por: Lacouture, Mario E., et al.
Publicado: (2011) -
Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review
por: Lacouture, Mario E., et al.
Publicado: (2017) -
Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines
por: Lacouture, Mario E., et al.
Publicado: (2020) -
Management of Dermatologic Toxicities Associated With Targeted Therapy
por: Lacouture, Mario E.
Publicado: (2016)